Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

Ascierto, P.A.; Fox, B.; Urba, W.; Anderson, A.C.; Atkins, M.B.; Borden, E.C.; Brahmer, J.; Butterfield, L.H.; Cesano, A.; Chen, D.; de Gruijl, T.; Dillman, R.O.; Drake, C.G.; Emens, L.A.; Gajewski, T.F.; Gulley, J.L.; Stephen Hodi, F.; Hwu, P.; Kaufman, D.; Kaufman, H.; Lotze, M.; McNeel, D.G.; Margolin, K.; Marincola, F.; Mastrangelo, M.J.; Maus, M.V.; Parkinson, D.R.; Romero, P.J.; Sondel, P.M.; Spranger, S.; Sznol, M.; Weiner, G.J.; Wiggington, J.M.; Weber, J.S.

doi:10.1136/jitc-2020-000878

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

Détails

Télécharger: 32300051_BIB_819D81E8FA74.pdf (404.41 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0

ID Serval

serval:BIB_819D81E8FA74

Type

Article: article d'un périodique ou d'un magazine.

Sous-type

Editorial

Collection

Publications

Institution

UNIL/CHUV

Titre

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

Périodique

Journal for immunotherapy of cancer

Auteur⸱e⸱s

Ascierto P.A., Fox B., Urba W., Anderson A.C., Atkins M.B., Borden E.C., Brahmer J., Butterfield L.H., Cesano A., Chen D., de Gruijl T., Dillman R.O., Drake C.G., Emens L.A., Gajewski T.F., Gulley J.L., Stephen Hodi F., Hwu P., Kaufman D., Kaufman H., Lotze M., McNeel D.G., Margolin K., Marincola F., Mastrangelo M.J., Maus M.V., Parkinson D.R., Romero P.J., Sondel P.M., Spranger S., Sznol M., Weiner G.J., Wiggington J.M., Weber J.S.

ISSN

2051-1426 (Electronic)

ISSN-L

2051-1426

Statut éditorial

Publié

Date de publication

04/2020

Peer-reviewed

Oui

Volume

8

Numéro

1

Langue

anglais

Notes

Publication types: Editorial
Publication Status: ppublish

Mots-clé

Betacoronavirus, Coronavirus Infections/diagnostic imaging, Coronavirus Infections/drug therapy, Coronavirus Infections/immunology, Coronavirus Infections/therapy, Drug Approval, Humans, Immunologic Factors/therapeutic use, Immunotherapy, Inflammation/blood, Inflammation/therapy, Interleukin-6/agonists, Neoplasms/therapy, Pandemics, Pneumonia, Viral/diagnostic imaging, Pneumonia, Viral/drug therapy, Pneumonia, Viral/immunology, Pneumonia, Viral/therapy, Receptors, Interleukin-6/agonists, immunomodulation, inflammation mediators

URN

urn:nbn:ch:serval-BIB_819D81E8FA749

OAI-PMH

oai:serval.unil.ch:BIB_819D81E8FA74

DOI

10.1136/jitc-2020-000878

Pubmed

32300051

Open Access

Oui

Création de la notice

25/04/2020 18:59